{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:23:07Z","timestamp":1793215387582,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-120336RB-I00"],"award-info":[{"award-number":["PID2020-120336RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-89714-R"],"award-info":[{"award-number":["SAF2017-89714-R"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["694717"],"award-info":[{"award-number":["694717"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["CP15\/00150"],"award-info":[{"award-number":["CP15\/00150"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["CPII20\/00010"],"award-info":[{"award-number":["CPII20\/00010"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10 LABX-0046"],"award-info":[{"award-number":["ANR-10 LABX-0046"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","award":["PFIS-FI19\/00153"],"award-info":[{"award-number":["PFIS-FI19\/00153"]}],"id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["AICO\/2019\/250"],"award-info":[{"award-number":["AICO\/2019\/250"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["AICO\/2021\/081"],"award-info":[{"award-number":["AICO\/2021\/081"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["APOTIP\/2020\/011"],"award-info":[{"award-number":["APOTIP\/2020\/011"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["CDEI-04\/20A"],"award-info":[{"award-number":["CDEI-04\/20A"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2019\/032"],"award-info":[{"award-number":["PROMETEO\/2019\/032"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00209"],"award-info":[{"award-number":["PI18\/00209"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/01450"],"award-info":[{"award-number":["PI18\/01450"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21-00220"],"award-info":[{"award-number":["PI21-00220"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/02045"],"award-info":[{"award-number":["PI21\/02045"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.phrs.2022.106638","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T12:17:27Z","timestamp":1672229847000},"page":"106638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Anti-inflammatory effects and improved metabolic derangements in ob\/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activity"],"prefix":"10.1016","volume":"187","author":[{"given":"Patrice","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Villarroel-Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Collado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Duplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Hennuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Garibotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo D.","family":"Enriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dacquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Piqueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Jes\u00fas","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Cabedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9710","key":"10.1016\/j.phrs.2022.106638_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","article-title":"The metabolic syndrome","volume":"375","author":"Eckel","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.phrs.2022.106638_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/jcm8050708","article-title":"Systemic inflammation in metabolic syndrome: increased platelet and leukocyte activation, and key role of CX(3)CL1\/CX(3)CR1 and CCL2\/CCR2 axes in arterial platelet-proinflammatory monocyte adhesion","volume":"8","author":"Marques","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.phrs.2022.106638_bib3","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2022.106638_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113535","article-title":"Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: an overview","volume":"221","author":"Villarroel-Vicente","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.ATV.0000250972.83623.61","article-title":"Activation of PPARbeta\/delta induces endothelial cell proliferation and angiogenesis","volume":"27","author":"Piqueras","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106638_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.phrs.2022.106638_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"23","key":"10.1016\/j.phrs.2022.106638_bib8","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1111\/bph.13029","article-title":"The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges","volume":"172","author":"Cheang","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106638_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ahj.2012.06.023","article-title":"Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects","volume":"164","author":"Rosenson","year":"2012","journal-title":"Am. Heart J."},{"issue":"11","key":"10.1016\/j.phrs.2022.106638_bib10","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1210\/me.2013-1427","article-title":"Minireview: challenges and opportunities in development of PPAR agonists","volume":"28","author":"Wright","year":"2014","journal-title":"Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106638_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdiacomp.2010.06.006","article-title":"Selective modulation of PPAR\u03b3 activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes","volume":"25","author":"Dunn","year":"2011","journal-title":"J. Diabetes Complicat."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib12","doi-asserted-by":"crossref","first-page":"267s","DOI":"10.3945\/ajcn.2009.28449E","article-title":"Selective peroxisome proliferator-activated receptor gamma (PPARgamma) modulation as a strategy for safer therapeutic PPARgamma activation","volume":"91","author":"Higgins","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"issue":"10","key":"10.1016\/j.phrs.2022.106638_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3858\/emm.2012.44.10.066","article-title":"Peroxisome proliferator-activated receptor \u03b4 agonist attenuates hepatic steatosis by anti-inflammatory mechanism","volume":"44","author":"Lee","year":"2012","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2022.106638_bib14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3390\/ijms19030913","article-title":"PPAR\u03b2\/\u03b4: a key therapeutic target in metabolic disorders","volume":"19","author":"Palomer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1189\/jlb.0508284","article-title":"Activation of PPARbeta\/delta inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release","volume":"86","author":"Piqueras","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106638_bib16","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1021\/acs.jnatprod.9b00003","article-title":"Polycerasoidol, a natural prenylated benzopyran with a dual PPAR\u03b1\/PPAR\u03b3 agonist activity and anti-inflammatory effect","volume":"82","author":"Bermejo","year":"2019","journal-title":"J. Nat. Prod."},{"issue":"6","key":"10.1016\/j.phrs.2022.106638_bib17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1182\/blood-2007-01-070607","article-title":"A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles","volume":"110","author":"Mateo","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.phrs.2022.106638_bib18","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI107470","article-title":"Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria","volume":"52","author":"Jaffe","year":"1973","journal-title":"J. Clin. Investig."},{"issue":"14","key":"10.1016\/j.phrs.2022.106638_bib19","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.biomaterials.2005.12.018","article-title":"Examination of the effects of poly(N-vinylpyrrolidinone) hydrogels in direct and indirect contact with cells","volume":"27","author":"Smith","year":"2006","journal-title":"Biomaterials"},{"issue":"48","key":"10.1016\/j.phrs.2022.106638_bib20","doi-asserted-by":"crossref","first-page":"45041","DOI":"10.1074\/jbc.M105197200","article-title":"Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway","volume":"276","author":"Martin","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4049\/jimmunol.1102942","article-title":"Retinoid X receptor agonists impair arterial mononuclear cell recruitment through peroxisome proliferator-activated receptor-gamma activation","volume":"189","author":"Sanz","year":"2012","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106638_bib22","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.4049\/jimmunol.1001043","article-title":"Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-kappaB activation and peroxisome proliferator-activated receptor-gamma upregulation","volume":"185","author":"Rius","year":"2010","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.phrs.2022.106638_bib23","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106638_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103963","article-title":"Design, synthesis, and biological evaluation of novel dual PPAR\u03b1\/\u03b4 agonists for the treatment of T2DM","volume":"101","author":"Ren","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.phrs.2022.106638_bib25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ejmech.2018.12.069","article-title":"Discovery of first-in-class thiazole-based dual FFA1\/PPAR\u03b4 agonists as potential anti-diabetic agents","volume":"164","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2022.106638_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104679","article-title":"A novel FFA1 agonist, CPU025, improves glucose-lipid metabolism and alleviates fatty liver in obese-diabetic (ob\/ob) mice","volume":"153","author":"Li","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"22","key":"10.1016\/j.phrs.2022.106638_bib27","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1016\/j.bmc.2006.07.029","article-title":"Novel 1,3-dicarbonyl compounds having 2(3H)-benzazolonic heterocycles as PPARgamma agonists","volume":"14","author":"Blanc-Delmas","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2022.106638_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100562","article-title":"Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation","volume":"9","author":"Zaafar","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2022.106638_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/JOE-15-0219","article-title":"Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis","volume":"227","author":"Andr\u00e9s-Blasco","year":"2015","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106638_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/jm2014293","article-title":"Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype","volume":"55","author":"Kuwabara","year":"2012","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.phrs.2022.106638_bib31","doi-asserted-by":"crossref","first-page":"E2563","DOI":"10.1073\/pnas.1621513114","article-title":"Structural basis for specific ligation of the peroxisome proliferator-activated receptor \u03b4","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.phrs.2022.106638_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.361","article-title":"Peroxisome proliferator-activated receptor \u03b1 activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway","volume":"5","author":"Jiao","year":"2014","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.phrs.2022.106638_bib33","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1074\/jbc.273.6.3285","article-title":"p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor","volume":"273","author":"Vanden Berghe","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2022.106638_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cardiores.2003.11.038","article-title":"Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis","volume":"61","author":"Monaco","year":"2004","journal-title":"Cardiovasc Res."},{"issue":"7","key":"10.1016\/j.phrs.2022.106638_bib35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.ijo.0802943","article-title":"Fenofibrate prevents Rosiglitazone-induced body weight gain in ob\/ob mice","volume":"29","author":"Carmona","year":"2005","journal-title":"Int. J. Obes."},{"issue":"5","key":"10.1016\/j.phrs.2022.106638_bib36","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/diacare.25.5.815","article-title":"Evaluation of liver function in type 2 diabetic patients during clinical trials","volume":"25","author":"Lebovitz","year":"2002","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.phrs.2022.106638_bib37","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jcmg.2014.07.017","article-title":"Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study","volume":"7","author":"Shah","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"9","key":"10.1016\/j.phrs.2022.106638_bib38","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-019-0563-7","article-title":"Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease","volume":"25","author":"Karlsson","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/s41467-017-00231-1","article-title":"CD206(+) M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors","volume":"8","author":"Nawaz","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-7075-11-10","article-title":"The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility","volume":"11","author":"Zhang","year":"2014","journal-title":"Nutr. Metab."},{"issue":"6","key":"10.1016\/j.phrs.2022.106638_bib41","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2004-0372","article-title":"Obesity, metabolic syndrome, and cardiovascular disease","volume":"89","author":"Grundy","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00395-011-0237-1","article-title":"The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update","volume":"107","author":"Zhang","year":"2012","journal-title":"Basic Res. Cardiol."},{"issue":"21 (Suppl. 1)","key":"10.1016\/j.phrs.2022.106638_bib43","first-page":"Ii27","article-title":"Endothelial function: a critical determinant in atherosclerosis?","volume":"109","author":"Landmesser","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2022.106638_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112460","article-title":"Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players","volume":"145","author":"Marques","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.phrs.2022.106638_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/ATVBAHA.107.149815","article-title":"Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells","volume":"28","author":"Fan","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106638_bib46","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.freeradbiomed.2012.05.045","article-title":"Activation of peroxisome proliferator-activated receptor-\u03b2\/-\u03b4 (PPAR\u03b2\/\u03b4) prevents endothelial dysfunction in type 1 diabetic rats","volume":"53","author":"Quintela","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"7203","key":"10.1016\/j.phrs.2022.106638_bib47","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nature07202","article-title":"Integration of metabolism and inflammation by lipid-activated nuclear receptors","volume":"454","author":"Bensinger","year":"2008","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.phrs.2022.106638_bib48","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00125-021-05442-2","article-title":"Liver-targeting drugs and their effect on blood glucose and hepatic lipids","volume":"64","author":"Gastaldelli","year":"2021","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.phrs.2022.106638_bib49","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/ijms21062061","article-title":"PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib50","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.diabres.2008.02.001","article-title":"Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus","volume":"81","author":"Kim","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"4","key":"10.1016\/j.phrs.2022.106638_bib51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1172\/JCI10843","article-title":"Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists","volume":"106","author":"Olefsky","year":"2000","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.phrs.2022.106638_bib52","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.0511253103","article-title":"PPARdelta regulates glucose metabolism and insulin sensitivity","volume":"103","author":"Lee","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"16","key":"10.1016\/j.phrs.2022.106638_bib53","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.3390\/ijms22168555","article-title":"The PPAR\u03b2\/\u03b4-AMPK connection in the treatment of insulin resistance","volume":"22","author":"Aguilar-Recarte","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.phrs.2022.106638_bib54","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/cmi.12336","article-title":"Inflammation and macrophage modulation in adipose tissues","volume":"16","author":"Vieira-Potter","year":"2014","journal-title":"Cell Microbiol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106638_bib55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106638_bib56","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106638_bib58","doi-asserted-by":"crossref","first-page":"10518","DOI":"10.1038\/s41598-017-11303-z","article-title":"M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes","volume":"7","author":"Bai","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822005849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822005849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:47:00Z","timestamp":1760914020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822005849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":58,"alternative-id":["S1043661822005849"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106638","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory effects and improved metabolic derangements in ob\/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activity","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106638"}}